Table 2.
Glycemic Controla
| PRE NON | PRE DM | PRE NON versus DM | GC NON | GC DM | GC NON versus DM | PRE versus GC NON | PRE versus GC DM | |
|---|---|---|---|---|---|---|---|---|
| Glucose tests/patient | 5 (3–10) | 6 (4–10) | 0.2019 | 5 (4–10) | 6 (4–10) | 0.4132 | 0.1351 | 0.8370 |
| Mean (mg/dl) | 126.3 (109.7–149.6) | 184.3 (146.8–227.0) | <0.0001 | 114.8 (103.7–128.2) | 127.3 (111.1–148.8) | <0.0001 | <0.0001 | <0.0001 |
| SD (mg/dl) | 25.6 (15.5–43.3) | 55.37 (32.5–83.6) | <0.0001 | 22.7 (14.5–33.9) | 36.37 (23.7–56.1) | <0.0001 | <0.0001 | <0.0001 |
| CV (%) | 20.4 (13.0–30.1) | 31.1 (19.8–43.4) | <0.0001 | 19.6 (13.3–28.6) | 28.8 (19.8–41.5) | <0.0001 | 0.2817 | 0.5184 |
| SHb (% patients) | 18 (1.6) | 17 (5.3) | 0.0003 | 46 (2.3) | 42 (6.8) | <0.0001 | 0.2150 | 0.4704 |
| MHc (% patients) | 35 (3.1) | 23 (7.2) | 0.0015 | 150 (7.5) | 69 (11.1) | 0.0059 | <0.0001 | 0.0724 |
a
Glucose tests/patient, mean, SD, and CV expres sed as median (IQR). These values represent the median of each patient's values. Results expressed as number (%) or median (IQR). Statistical testing by Chi square test for comparisons of percentages and Wilcoxon rank-sum test for comparisons of continuous variables.
b
SH = blood glucose <40 mg/dl.
c
MH = blood glucose 40–59 mg/dl.